欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EE/H/0331/003
药品名称
Olmesartan medoxomil HCTZ Teva
活性成分
Hydrochlorothiazide 12.5 mg
Olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva B.V. Swensweg 5, Haarlem, 2031 GA,Netherlands
参考成员国 - 产品名称
Estonia (EE)
互认成员国 - 产品名称
Spain (ES)
Portugal (PT)
Italy (IT)
Bulgaria (BG)
Olmesta Plus
Germany (DE)
Olmesartan AbZ comp. 40 mg/12,5 mg Filmtabletten
Netherlands (NL)
许可日期
2021/12/16
最近更新日期
2024/11/15
药物ATC编码
C09DA08 olmesartan medoxomil and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
Public AR_EE_H_0331_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase